Brief: Biontech To Showcase Oncology Late-Stage Pipeline Progress At ESMO 2026
Mon 11:51
BRIEF-Biontech To Showcase Oncology Late-Stage Pipeline Progress At ESMO 2026 Oct 19 (Reuters) - BIONTECH SE 22UAy.DE:
TO SHOWCASE ONCOLOGY LATE-STAGE PIPELINE PROGRESS AND PUMITAMIG NOVEL-NOVEL COMBINATION DATA AT ESMO 2026
Source text: ID:nGNX8HmXjX
Further company coverage: [22UAy.DE]
(Gdansk Newsroom)
((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on BioNTech SE
See all newsBioNTech, Gilead to test drug combination in advanced breast cancer trial
Brief: BioNTech Starts Phase 3 Trial of Pumitamig Plus Gilead's Trodelvy for Breast Cancer
Brief: Biontech To Showcase Oncology Late-Stage Pipeline Progress At ESMO 2026
BioNTech's mRNA cancer therapy misses first goal in head and neck trial (updated)
BioNTech's mRNA cancer therapy misses first goal in head and neck trial